When Do I Transition from Meaningful Use Stage 1 to Meaningful Use Stage 2?

If you are a Medicare Eligible Professional, and you attested for Meaningful Use in 2011, 2012 or 2013 and attested each following year, you should attest for Stage 2 in 2015.

If you are a Medicaid Eligible Professional, you should start Stage 2 after you have adopted, upgraded, or implemented a certified EHR in your first year, followed by a 90-day reporting period in year 2, and the entire next year thereafter.

Simplify Stage 2 with the best-designed EHR on the market

Watch Tour

What are the Requirements for Meaningful Use Stage 2?

Stage 1

Eligible Professionals

  • 13 core objectives
  • 5 menu objectives
  • 18 total objectives
  • +9 CQMs

Stage 2

Eligible Professionals

  • 17 core objectives
  • 3 menu objectives
  • 20 total objectives
  • +9 CQMs

To meet the requirements of Meaningful Use Stage 2, you must fulfill the required 17 Core Objectives, along with 3 of the available Menu Objectives. All eligible professionals, no matter what stage you are in, must meet 9 clinical quality measures to meet MU requirements. Learn more about clinical quality measures.

Meaningful Use Stage 2 Core Objectives

Core Objective
1. CPOE for Medication/Labs/Radiology
2. eRx
3. Record Demographics
4. Vital Signs
5. Smoking Status
6. Clinical Decision Support
7. Patient Electronic Access
8. Clinical Summaries
9. Protect Health Information
10. Clinical Lab Test Results
11. List of Patients by Specific Conditions
12. Send Patient Reminders
13. Patient Education Resources
14. Medication Reconciliation
15. Transition of Care Records
16. Submit data to immunization registry
17. Secure Electronic Messaging
Measurement Threshold
> 60% of medication, > 30% of labs and radiology orders are recorded using CPOE
> 50% of all permissible prescriptions are transmitted electronically and compared to at least one drug formulary
> 80% of all unique patients have preferred language, gender, race, ethnicity and date of birth recorded
> 80% of all unique patients have height and weight recorded, patients > 3 years old also need blood pressure recorded
> 80% of unique patients (> 13 years old) have smoking status recorded
Implement 5 rules related to at least 4 Clinical Quality Measures; enable Drug-drug and Drug-allergy interaction checks for entire period
> 50% of patients have access to clinical data within 4 business days; > 5% of patients view, download or transmit clinical data
Clinical summaries are provided to patients within 1 business day for > 50% of office visits
Conduct or review security risk analysis
> 55% of all clinical lab test orders are resulted as structured data and incorporated into the EHR
Generate at least one report listing patients with a specific condition
> 10% of patients with 2 or more office visits within the last 24 months are provided reminders
> 10% are provided patient specific education resources
> 50% of transitions in care must have medication reconciliation
Provide a summary of care for > 50% of transitions of care and referrals, > 10% of the total number of transitions or referrals are submitted electronically, perform at least one successful electronic exchange of a summary of care document with a different EHR technology vendor or with a CMS designated test EHR
Ongoing submission of electronic data to immunization registries
> 5% of unique patients sent a secure message using the electronic messaging function

Meaningful Use Stage 2 Menu Objectives (Must Select 3)

Menu Objective
1. Submit syndromic surveillance data to public health registry
2. Electronic Notes
3. Imaging Results
4. Family Health History
5. Cancer Cases Submitted to Cancer Registry
6. Specific Cases Submitted to Specialized Registry
Measurement Threshold
Ongoing Submission of electronic syndromic surveillance data to public health agencies
> 30% of unique patients must have at least one electronic progress note created, edited and signed for at least one office visit
> 10% of all tests that yield an image must be accessible through an EHR
> 20% of unique patients have family health history recorded for one or more first-degree relatives
Ongoing Submission of electronic data to public health central cancer registry
Ongoing Submission of specific case information to specialized registry